Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
TGTX
TGTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest TGTX ETF News Today | Earnings, Events & Price Alerts
TGTX News
TG Therapeutics Reports Strong Q4 2025 Earnings and Growth Outlook
5d ago
seekingalpha
TG Therapeutics Q4 Earnings Miss Expectations with Revenue Growth
5d ago
seekingalpha
TG Therapeutics Set to Announce Q4 Earnings on February 26
6d ago
seekingalpha
TG Therapeutics to Host Q4 2025 Earnings Call
Feb 23 2026
Newsfilter
BRIUMVI Shows Significant Efficacy Over Five Years in MS Treatment
Feb 17 2026
Newsfilter
Soleus Capital Increases Stake in Celcuity
Feb 13 2026
Fool
TG Therapeutics Launches NextInMS Platform to Support MS Patients
Feb 09 2026
stocktwits
TG Therapeutics Partners with Christina Applegate to Raise MS Awareness
Feb 08 2026
Newsfilter
TG Therapeutics Presents BRIUMVI Data at ACTRIMS Annual Meeting
Feb 06 2026
Newsfilter
Hussman Strategic Advisors Exits Entire Position in TG Therapeutics
Feb 03 2026
Fool
Goldman Sachs Raises TG Therapeutics Price Target to $39, Briumvi Now Available in 16 Countries
Jan 15 2026
stocktwits
S&P 500 Index Falls 0.53% as Tech Stocks Weigh Down Market
Jan 15 2026
NASDAQ.COM
S&P 500, Dow, and Nasdaq Decline Amid Rising Geopolitical Risks
Jan 14 2026
NASDAQ.COM
S&P 500, Dow, and Nasdaq Decline; Nasdaq Hits One-Week Low
Jan 14 2026
NASDAQ.COM
TG Therapeutics (TGTX) Projects $616 Million Revenue in 2025, Exceeding Analyst Estimates
Jan 14 2026
stocktwits
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
Jan 14 2026
Benzinga
Show More News
